Summary
Breast secretions can be classified into two types according to their major protein components. Type I fluids contain Zn-α2-glycoprotein, apolipoprotein D, and gross cystic disease fluid protein-15, while Type II fluids are characterized by the presence of lactoferrin, lysozyme, and α-lactalbumin. In this study, the polypeptide composition of breast secretions from 719 nonlactating women was evaluated by using polyacrylamide gel electrophoresis. The required amount for the analysis (1 µl) was obtained from 50% of control women and from 75% of women with mammary disease. There were more secretors in premenopausal than in postmenopausal women, as well as in parous than in nulliparous women. Evaluation of factors affecting protein composition of breast secretions revealed that Type II fluids were found in the majority of women who had given birth in the last four years and in a high proportion of oral contraceptive users. After excluding both of these groups, Type II fluids were detected in 47% of patients with breast cancer, but only in 8% of control women and in 16% of women with benign breast diseases. Taken together, these results suggest that protein analysis of breast secretions could be an useful tool for the study of breast pathologies.
Similar content being viewed by others
References
Sartorius OW, Smith HS, Morris P, Benedict D, Friesen L: Cytologic evaluation of breast fluid in the detection of breast disease. JNCI 59: 1073–1078, 1977
Petrakis NL: Physiologic, biochemical and cytologic aspects of nipple aspirate fluid. Breast Cancer Res Treat 8: 7–19, 1986
Petrakis NL, Wrensch MR, Ernster VL, Miike R, King EB, Goodson WH: Prognostic significance of atypical epithelial hyperplasia in nipple aspirates of breast fluid. Lancet ii: 505, 1987
Wynder EL, Hill P: Prolactin, oestrogens, and lipids in breast fluid. Lancet ii: 840, 1977
Miller WR, Humeniuk V, Forrest APM: Factors affecting dehydroepiandrosterone sulphate levels in human breast secretions. Breast Cancer Res Treat 1: 267–272, 1981
Hill P, Garbaczewski L, Wynder EL: Testosterone in breast fluid. Lancet i: 761, 1983
Rose DP: Hormones in breast fluid. Breast Cancer Res Treat 8: 25–28, 1986
Petrakis NL, Gruenke LD, Beelen TC, Castagnoli N, Craig JC: Nicotine in breast fluid of non-lactating women. Science 199: 303–305, 1978
Petrakis NL, Maack CA, Lee RE, Lyon M: Mutagenic activity in nipple aspirates of human breast fluid. Cancer Res 40: 188–189, 1980
Scott WN, Miller WR: The mutagenic activity of human breast secretions. J Cancer Res Clin Oncol 116: 499–502, 1990
Hagler L, Coppes RI, Block HB, Hofeldt FD, Herman RH: Clinical implications of lactose-positive breast secretions in nonpuerperal females. Obstet Gynecol 46: 302–307, 1975
Chotiner HC, Adams HR, Splekerman AM, Gilliand PF, Newmark SR: Lactose and casein content of nonpuerperal breast secretion. J Reprod Med 22: 267–270, 1979
Kulski JK, Hartmann PE, Saint WJ, Giles PF, Gutteridge DH: Changes in the milk composition of nonpuerperal women. Am J Obstet Gynecol 139: 597–604, 1981
Yap PL, Miller WR, Humeniuk V, Pryde EAD, Mirtle CL, McCleland DBL: Milk protein concentrations in the mammary secretions of non-lactating women. J Reprod Immunol 3: 49–58, 1981
Petrakis NL, Lim ML, Miike R, Lee RE, Morris M, Lee L, Mason L: Nipple aspirate fluids in adult nonlactating women-lactose content, cationic Na+, K+, Na+/K+ ratio, and coloration. Breast Cancer Res Treat 13: 71–78, 1989
Sánchez LM, Vizoso F, Díez-Itza I, López-Otín C: Identification of the major protein components in breast secretions from women with benign and malignant breast diseases. Cancer Res 52: 95–100, 1992
Dixon WJ (ed) BMDP statistical software. University of California Press, Berkeley, 1986
Petrakis NL, Ernster VL, Sacks ST, King EB, Schweitzer RJ, Hunt TK, King MC: Epidemiology of breast fluid secretion: Association with breast cancer risk factors and cerumen type. JNCI 67: 277–284, 1981
Wynder EL, Hill P, Laakso K, Littner R, Kettunen KL: Breast secretion in Finnish women: A metabolic epidemiologic study. Cancer 47: 1444–1450, 1981
Wrensch MR, Petrakis NL, Gruenke LD, Ernster VL, Miike R, King EB, Hauck WW: Factors associated with obtaining nipple aspirate fluid: analysis of 1428 women and literature review. Breast Cancer Res Treat 15: 39–51, 1990
Miller WR, Elton RA, Loudon N: Oral contraceptive steroids and breast secretions. Br J Obstet Gynaecol 96: 967–972, 1989
Petrakis NL, Wrensch MR, Ernster VL, Miike R, Murai J, Simberg N, Siiteri PK: Influence of pregnancy and lactation on serum and breast fluid estrogen levels: implications for breast cancer risk. Int J Cancer 40: 587–591, 1987
Woods KL, Cove DH, Howell A: Predictive classification of human breast carcinomas based on lactalbumin synthesis. Lancet ii: 14–16, 1977
Schultz GS, Ebner KE: α-Lactalbumin levels in human mammary tumors, sera, and mammary cell culture lines. Cancer Res 37: 4489–4492, 1977
Rose HN, McGrath CM: α-Lactalbumin production in human mammary carcinoma. Science 190: 673–675, 1975
Kleinberg DL: Human α-lactalbumin: measurement in serum and in breast cancer organ cultures by radioimmunoassay. Science 190: 276–278, 1975
Topper YJ, Freeman CS: Multiple hormone interactions in the developmental biology of the mammary gland. Physiol Rev 60: 1049–1106, 1980
Welsch CW, Nagasawa H: Prolactin and murine mammary tumorigenesis: a review. Cancer Res 37: 951–963, 1977
L'Hermite M, L'Hermite-Baleriaux M: Prolactin and breast cancer. Eur J Cancer Clin Oncol 24: 955–958, 1988
Love RR, Rose DR, Surawicz TS, Newcomb PA: Prolactin and growth hormone levels in premenopausal women with breast cancer and healthy women with a strong family history of breast cancer. Cancer 68: 1401–1405, 1991
Rose DP, Berke B, Cohen LA, Lahti H: A comparison of serum and breast duct fluid-immunoassayable prolactin and growth hormone with bioassayable lactogenic hormones in healthy women and patients with cystic breast disease. Cancer 60: 2761–2765, 1987
Wrensch MR, Petrakis NL, Gruenke LD, Miike R, Ernster VL, King EB, Hauck WW, Craig JC, Goodson WH III: Breast fluid cholesterol and cholesterol β-epoxide concentrations in women with benign breast disease. Cancer Res 49: 2168–2174, 1989
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vizoso, F., Sánchez, L.M., Díez-Itza, I. et al. Factors affecting protein composition of breast secretions from nonlactating women. Breast Cancer Res Tr 23, 251–258 (1992). https://doi.org/10.1007/BF01833522
Issue Date:
DOI: https://doi.org/10.1007/BF01833522